Navigation Links
CNA Presents New Data on Sutter's Medical Redlining
Date:10/25/2007

o just 6% at CPMC.

-- 40 percent of in-patient hospital expected payments at St. Luke's are

Medi-Cal -- compared to just 7 percent at CPMC.

-- 51 percent of St. Luke's patient discharges come from just three zip

codes adjacent to the hospital -- compared to 22 percent of CPMC's

hospital patients, an indication that St. Luke's patient base is drawn

heavily from surrounding neighborhoods.

-- From one-fourth to nearly half of St. Luke's patients from five zip

codes that account for 63 percent of all the hospital's discharge have

incomes under 200 percent of the poverty level. For the five top zip

codes for CPMC patients, the comparable income levels range from 8

percent to 28 percent.

"There can be no mistaking this data," says Castillo. "St. Luke's serves a far greater percentage of Latino and African-American patients than CPMC who will be unfairly harmed by the closure."

"The data also demonstrates the impact on low-income neighborhoods, who are already medically underserved, and who typically have a much harder time traveling to medical facilities away from their neighborhoods," said Castillo.

A report in the October 24/31 issue of JAMA, the Journal of the American Medical Association documents the health consequences of declining income levels in the U.S. One of its points is that for lower income Americans, "traveling across town to access better resources or health care facilities is often beyond their means."

"All San Franciscans will be harmed by the closure of St. Luke's and the unwarranted loss of hospital and emergency care services. It stresses the entire medical safety net of the city, which is especially dangerous in the advent of an emergency, from earthquakes to fires to major traffic gridlock," said Castillo.

"But some communities will endure greater harm than others. Sutter's desire to re-apportion its patient base to higher income
'/>"/>

SOURCE California Nurses Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Check if your “Favourite medical web-site” is indulging in Quackey
8. Teens turning to Internet for medical queries
9. Robots craft medical history
10. NBE to conduct test for medical students from abroad
11. Air pollution combined with greater medical needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...ios Spanos was shocked when his doctor discovered ... his body’s largest blood vessel, the aorta, durin...o symptoms, and was relieved to find out that the ...had been caught while it was still small. For the...
... A brewery in Japan launched production of unusual...farmer who was looking for ways to put his milk su...k will be available in the store shelves Thursday,...akashibetsu, on the country's northernmost island ...
... are planning to whiten your teeth by bleaching th...it done by unqualified people could cause consider...alons are offering teeth whitening by unqualified ...l bleach," said Christopher Orr, president of the ...
...tors and nurses who work in the developing world w...challenges, according to ‘Meeting the Health needs... The BMA’s International Committee surveyed 79 UK...including 67 doctors, who had recently worked in A...
Other Medicine News:Health News:Early Detection of Artery Weakening Can Be a Life-Saver 2Health News:Early Detection of Artery Weakening Can Be a Life-Saver 3Health News:Health Workers Need Better Preparation for Developing World 2
(Date:7/23/2008)...publication in July print edition of Clinical ...IANAPOLIS, July 23 /- A Roche Diagnos...-terminal pro-B-type natriuretic peptide,(NT-proBN...isk,stratification in predicting the risk of cardi...ed with non-steroidal anti-inflammatory drugs of,t...
(Date:7/23/2008)...Areas of the Body Have Greater Concentrations of,S...wswire-USNewswire/ -- Fat removed,from the lower a...nd to be,an excellent source of stem cells, with h... the body, reports a Brazilian-based study in Augu...ficial medical journal of the,American Society of ...
(Date:7/22/2008)...uly 22 /- Following a,thoro...d of Progen,Pharmaceuticals Limited (ASX: PGL; Nas...d the PI-88 phase 3 study in liver cancer. Progen ...xisting portfolio of compounds and,the company wil...d,opportunities through Merger & Acquisition activ...
(Date:7/22/2008)...uss Development Plan Completed Successfully, DUBL...rin Corporation,plc (NASDAQ: AMRN ) today announc... the U.S. Food and Drug Administration (FDA) to di...e treatment of,hypertriglyceridemia. Following the... 3 with AMR101 in hypertriglyceridemia., Dr. Decl...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 1Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 2Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 3Whole Foods Market 28R 29 Announces Eco Conscious Youth Hosts for Whole Earth Generation 28TM 29 Show 15624 4Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 1Crannose 28TM 29 Extra Strength Womens Health Formula Targets Urinary Tract Infections 15620 2Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 1Tengion Announces European Orphan Drug Designation for Neo Bladder Augment 4328 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 1China Bio Energy Reports Fiscal 2007 Financial Results 4324 2China Bio Energy Reports Fiscal 2007 Financial Results 4324 3China Bio Energy Reports Fiscal 2007 Financial Results 4324 4China Bio Energy Reports Fiscal 2007 Financial Results 4324 5China Bio Energy Reports Fiscal 2007 Financial Results 4324 6China Bio Energy Reports Fiscal 2007 Financial Results 4324 7China Bio Energy Reports Fiscal 2007 Financial Results 4324 8China Bio Energy Reports Fiscal 2007 Financial Results 4324 9China Bio Energy Reports Fiscal 2007 Financial Results 4324 10China Bio Energy Reports Fiscal 2007 Financial Results 4324 11
...s Efficacy at Improving Glycemic Control and,Reduc..., Ill., June 23, 2007 /PRNewswire/ -- VeroScience,...rtner S2 Therapeutics,Inc., reported today the re...the overall and cardiovascular safety of Cycloset(...mesylate) in subjects,with type 2 diabetes. The st...
...--Jun 25, 2007 - HepaLife Technologies, Inc.,(OTCB...that new,data presented at an international influe...,s patented PBS-1 cell line outperforms,current ce...us,inside its cells. The most important step towar...against a targeted virus is the,ability to efficie...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 6
...y Biotech Captia™ Varicella- Zoster Virus (VZV...s intended for the detection and quantitative dete...dividual serum specimens may be used for the deter...convalescent, may be used to demonstrate seroconve...
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as
The Trinity Biotech Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody in human serum to Mumps for the determination of immunological experi
The DIAGNOSTIC AUTOMATION, INC. (DAI) Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Mumps virus in human sera. In
Medicine Products: